Welcome to the Pfizer Co-Pay Portal

ELELYSO^® (taliglucerase alfa)
Terms and Conditions: By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Patient must have private insurance. Offer is not valid for cash paying patients. The value of this Co-pay Card is limited to a maximum of $15,000 per calendar year.
• This co-pay card is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs.
• You must deduct the value of this co-pay card from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the co-pay card to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. You should not use the co-pay card if your insurer or health plan prohibits use of manufacturer co-pay cards.
• Patient must be 4 years of age or older for redemption of co-pay card for ELELYSO.
• This co-pay card is not valid for Massachusetts residents whose prescriptions are covered in whole or in part by third party insurance.
• This co-pay card is not valid where prohibited by law.
• Co-pay card cannot be combined with any other savings, free trial or similar offer for the specified prescription.
• Co-pay card will be accepted only at participating pharmacies.
• If your pharmacy does not participate, you may be able to submit a request for a rebate in connection with this offer.
• This co-pay card is not health insurance.
• The co-pay program is available only through the Gaucher Personal Support program. For any questions, please call Gaucher Personal Support at 1-855-ELELYSO (1-855-353-5976).
• Offer good only in the U.S. and Puerto Rico.
• Co-pay card is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• No membership fee.
• Data related to your redemption of the co-pay card may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this offer without notice.
• Offer expires 12/31/2024.

For more information, visit our website www.elelyso.com, call 1-855-353-5976, or contact us at 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.

ELREXFIO™ (elranatamab-bcmm)
Terms and Conditions: By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for ELREXFIO is not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients. With this program, eligible patients may pay as little as $0 co-pay per ELREXFIO treatment, subject to a maximum benefit of $25,000 per calendar year for out-of-pocket expenses for ELREXFIO including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $25,000 you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of ELREXFIO. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• Patient must be 18 years of age or older for redemption of co-pay card.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, P.O. Box 220366, Charlotte, NC 28222.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

INFLECTRA^® (infliximab-dyyb)
Terms and Conditions: By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions below:

• The Pfizer enCompass^® Co-Pay Assistance Program for INFLECTRA is not valid for patients who are enrolled in a state- or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients. With this program, eligible patients may pay as little as $0 co-pay per INFLECTRA treatment, subject to a maximum benefit of $10,000 to $20,000 per calendar year for out-of-pocket expenses for INFLECTRA, including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $10,000 to $20,000, you will be responsible for the remaining out-of-pocket costs.
• Patient must have private insurance with coverage of INFLECTRA. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer enCompass Co-Pay Assistance Program, call Pfizer enCompass at 1-844-722-6672, or write to Pfizer enCompass Co-Pay Assistance Program at 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

NIVESTYM^® (filgrastim-aafi)
Terms and Conditions: By using this Co-Pay Program for Injectables program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for NIVESTYM is not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients.
• With this program, eligible patients may pay as little as $0 co-pay per NIVESTYM treatment, subject to a maximum benefit of $4,000 to $10,000 per calendar year for out-of-pocket expenses for NIVESTYM including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $4,000 to $10,000 you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of NIVESTYM. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• This program is not valid where prohibited by law. The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, P.O. Box 220366, Charlotte, NC 28222.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

NYVEPRIA^® (pegfilgrastim-apgf)
Terms and Conditions: By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for NYVEPRIA is not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients. With this program, eligible patients may pay as little as $0 co-pay per NYVEPRIA treatment, subject to a maximum benefit of $4,000 to $10,000 per calendar year for out-of-pocket expenses for NYVEPRIA including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $4,000 to $10,000 you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of NYVEPRIA. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf. You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, P.O. Box 220366, Charlotte, NC 28222.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

RUXIENCE^® (rituximab-pvvr)
Terms and Conditions: By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for RUXIENCE^® and the Pfizer enCompass Co-Pay^® Assistance Program for RUXIENCE are not valid for patients who are enrolled in a state- or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients.
• Patients prescribed RUXIENCE for pemphigus vulgaris are not eligible for this co-pay savings program.
• With this program, eligible patients may pay as little as $0 co-pay per RUXIENCE treatment, subject to a maximum benefit of $25,000 per calendar year for out-of-pocket expenses for RUXIENCE, including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum benefit, you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of RUXIENCE. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• Patient must be 18 years of age or older for redemption of co-pay card for RUXIENCE.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable. No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables for RUXIENCE, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, P.O. Box 220366, Charlotte, NC 28222. For more information about the Pfizer enCompass Co-Pay Assistance Program for RUXIENCE for non-oncology indications, call Pfizer enCompass at 1-844-722-6672, or write to Pfizer enCompass Co-Pay Assistance Program, 2730 S. Edmonds Lane, Suite 300, Lewisville, TX 75067.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

TRAZIMERA^® (trastuzumab-qyyp)
Terms and Conditions: By using this Co-Pay Program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for TRAZIMERA is not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients. With this program, eligible patients may pay as little as $0 co-pay per TRAZIMERA treatment, subject to a maximum benefit of $25,000 per calendar year for out-of-pocket expenses for TRAZIMERA including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $25,000 you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of TRAZIMERA. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• Patient must be 18 years of age or older for redemption of co-pay card.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, P.O. Box 220366, Charlotte, NC 28222.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.

ZIRABEV^® (bevacizumab-bvzr)
Terms and Conditions: By using this program, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

• The Pfizer Oncology Together™ Co-Pay Savings Program for Injectables for ZIRABEV is not valid for patients who are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud").
• Program offer is not valid for cash-paying patients.
• Patients prescribed ZIRABEV for hepatocellular carcinoma are not eligible for this co-pay savings program.
• With this program, eligible patients may pay as little as $0 co-pay per ZIRABEV treatment, subject to a maximum benefit of $25,000 per calendar year for out-of-pocket expenses for ZIRABEV including co-pays or coinsurances. The amount of any benefit is the difference between your co-pay and $0. After the maximum of $25,000 you will be responsible for the remaining monthly out-of-pocket costs.
• Patient must have private insurance with coverage of ZIRABEV. This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other private health or pharmacy benefit programs.
• You must deduct the value of this assistance from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
• You are responsible for reporting use of the program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay assistance programs.
• Patient must be 18 years of age or older for redemption of co-pay card.
• This program is not valid where prohibited by law.
• The benefit under the program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
• This program cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as "accumulator" or "maximizer" programs).
• Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the program.
• Co-pay card will be accepted only at participating pharmacies.
• This program is not health insurance.
• This program is good only in the U.S. and Puerto Rico.
• This program is limited to 1 per person during this offering period and is not transferable.
• No other purchase is necessary.
• Data related to your redemption of the program assistance may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer's programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other assistance redemptions and will not identify you.
• Pfizer reserves the right to rescind, revoke or amend this program without notice.
• This program may not be available to patients in all states.
• For more information about Pfizer, visit www.pfizer.com. For more information about the Pfizer Oncology Together Co-Pay Savings Program for Injectables, visit pfizeroncologytogether.com, call 1-877-744-5675, or write to Pfizer Oncology Together Co-Pay Savings Program for Injectables, P.O. Box 220366, Charlotte, NC 28222.
• Program terms and offer will expire at the end of each calendar year. Before the calendar year ends, you will receive information and eligibility requirements for continued participation.